Provided by Tiger Trade Technology Pte. Ltd.

iShares Global Healthcare ETF

103.66
+0.47620.46%
Volume:14.07K
Turnover:1.45M
Market Cap:4.37B
PE:-100.80
High:103.71
Open:103.02
Low:102.54
Close:103.18
52wk High:107.69
52wk Low:85.36
Shares:42.15M
Float Shares:42.15M
Volume Ratio:0.15
T/O Rate:0.03%
Dividend:1.45
Dividend Rate:1.39%
EPS(TTM):-1.0283
EPS(LYR):-1.0283
ROE:-8.66%
ROA:0.90%
PB:1.13
PE(LYR):-100.80

Loading ...

Viking Therapeutics Stock Surges 35%. It Could Challenge Lilly and Novo's Obesity Empire

Dow Jones
·
1 hour ago

Eli Lilly Price Target Maintained with a $1250.00/Share by TD Cowen

Dow Jones
·
Just now

Dow Falls 134 Points on Losses for Shares of Cisco, JPMorgan Chase

Dow Jones
·
1 hour ago

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)

TIPRANKS
·
1 hour ago

Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up

Reuters
·
2 hours ago

Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.

Dow Jones
·
2 hours ago

Hospital Corporation of China Reshapes Board to Bolster Governance and Compliance

TIPRANKS
·
3 hours ago

DePuy Synthes Showcases Next-Generation Trauma Innovations at OTA 2026

Reuters
·
3 hours ago

J&J DePuy Synthes to Showcase Next-Generation Trauma Devices at Orthopaedic Trauma Association Annual Meeting

Reuters
·
3 hours ago

OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath

GlobeNewswire
·
3 hours ago

PetVivo Holdings Adds Veteran Leader to Board

TIPRANKS
·
3 hours ago

Merck Gets FDA Label Update for WINREVAIR Based on HYPERION Trial

MT Newswires Live
·
4 hours ago

Merck says FDA approves update for U.S. product label for Winrevair

TIPRANKS
·
4 hours ago

U.S. FDA Approves Update to the Label for Winrevair to Include Data from the Phase 3 Hyperion Trial Evaluating Adults Recently Diagnosed with Pulmonary Arterial Hypertension

Reuters
·
4 hours ago

Merck Says Phase 3 Hyperion Trial Shows Winrevair Cuts PAH Clinical Worsening Risk 76%

Reuters
·
4 hours ago

AbbVie: EC approves Rinvoq to treat polyarticular juvenile idiopathic arthritis

TIPRANKS
·
5 hours ago

AbbVie Announces European Commission Approval of Rinvoq (Upadacitinib)

Reuters
·
8 hours ago

AbbVie Says EU Approves Rinvoq for Children with Polyarticular Juvenile Idiopathic Arthritis

Reuters
·
9 hours ago

Abbvie Announces European Commission Approval of Rinvoq® (Upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis

THOMSON REUTERS
·
9 hours ago

Abbvie - Rinvoq Approved in EU for Pjia in Patients Aged Two Years and Older

THOMSON REUTERS
·
9 hours ago